How much does a box of Avatrombopag cost and price comparison in different regions

Avatrombopag (Avatrombopag) is an oral drug used to treat chronic immune thrombocytopenia (ITP). It has been marketed in China and is included in medical insurance. The domestic selling price of this drug is closely related to medical insurance policies, and the actual amount paid by patients will vary depending on the region and medical insurance reimbursement ratio.

In China, the main specifications of avatrombopag are 20mg×10 tablets and 20mg×15 tablets. According to the latest market information, the price of 20 mg The specific medical insurance reimbursement ratio and patient out-of-pocket amount need to be determined according to the policies of the local hospital pharmacy.

In foreign markets, the price of generic drugs of avatrombopag is relatively low. For example, the ingredients of generic avatrombopag produced in countries such as Laos and Bangladesh are basically the same as those of the original drug, and the price is usually around a few hundred yuan. These generic drugs provide patients with more economical treatment options, but it is important to note that purchasing and using these generic drugs may face risks in terms of legality and quality control.

Overall, the price of avatrombopag in China is relatively high, but the coverage of medical insurance policies can effectively reduce the financial burden on patients. When choosing medication, patients should fully consider the efficacy, safety and economy of the drug, and make the decision that best suits their situation based on the doctor's advice.

Reference materials:https://www.drugs.com/